CytoSorbents Corp CTSO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
-
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
-
CytoSorbents Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
-
CytoSorbents to Appeal Canadian Rejection of License Application for DrugSorb-ATR
Trading Information
- Previous Close Price
- $0.48
- Day Range
- $0.46–0.50
- 52-Week Range
- $0.37–1.39
- Bid/Ask
- $0.45 / $0.46
- Shares Outstanding
- 62.79M
- Market Cap
- $28.65M
- Volume/Avg
- 25,222 / 148,363
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.67
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- < 0.01%
Company Profile
CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 129
- Website
- https://www.cytosorbents.com
Valuation
|
Metric
|
CTSO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 11.43 |
Price/Sales | 0.67 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
CTSO
|
|---|---|
Quick Ratio | 0.73 |
Current Ratio | 1.09 |
Interest Coverage | −3.28 |
Quick Ratio
CTSO
Profitability
|
Metric
|
CTSO
|
|---|---|
Return on Assets (Normalized) | −19.99% |
Return on Equity (Normalized) | −105.96% |
Return on Invested Capital (Normalized) | −17.23% |
Return on Assets
CTSO
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Jtbptbqsl | Zntzmmy | $154B | |||
| Stryker Corp
SYK
| Hdvxbbxwy | Bxtcs | $115B | |||
| Medtronic PLC
MDT
| Ngvbjmdk | Hkmph | $100B | |||
| Boston Scientific Corp
BSX
| Wxptksyvx | Rctlnd | $67B | |||
| Edwards Lifesciences Corp
EW
| Cnqtkyyrh | Nctkqw | $50B | |||
| Siemens Healthineers AG ADR
SMMNY
| — | Xdxvt | $45B | |||
| Siemens Healthineers AG Registered Shares
SEMHF
| — | Jhtz | $45B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| Lmxwcdkvv | Mwvp | $28B | |||
| DexCom Inc
DXCM
| Ymbcvrdjtb | Hfddzp | $27B | |||
| Koninklijke Philips NV
RYLPF
| Yyjljrfy | Crxbz | $26B |
United States